VBCG
GDRX icon

Valley Brook Capital Group’s GoodRx Holdings GDRX Stock Holding History

Valley Brook Capital Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29
Closed -$1K – 473
2020
Q4 		$1K Buy
+29
New +$1.33K ﹤0.01% 390

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Valley Brook Capital Group's GDRX Position: Q1 2021 in Review

Valley Brook Capital Group sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 29 shares — an estimated $1K sold.

Valley Brook Capital Group first reported a position in GDRX in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

  • Valley Brook Capital Group reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 29 GoodRx Holdings shares in Q1 2021, an estimated $1K.
  • Valley Brook Capital Group first reported a position in GoodRx Holdings in Q4 2020 and held it in 1 quarter.
  • Valley Brook Capital Group's GoodRx Holdings position peaked at $1K in Q4 2020.
  • 205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on Valley Brook Capital Group's 13F filing for Q1 2021, filed 6 May 2021.